MONROVIA, Calif., Aug. 3, 2011 /PRNewswire via COMTEX/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in the 2011 Canaccord Genuity Growth Conference at the Intercontinental Hotel in Boston on Tuesday, August 9, 2011 at 3:30 p.m. Eastern Time.

Barry G. Caldwell, President and CEO, will review the company's business strategy and recent corporate developments. STAAR will offer a live video webcast of its presentation on the Company's website, http://www.staar.com/, under Investor Information. An archived replay of the presentation will be available for 30 days, also at http://www.staar.com/.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." A lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." Over 225,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at http://www.staar.com/ or call 626-303-7902.

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.

SOURCE STAAR Surgical Company